2-Hydroxyethyl disulfide mono-tosylate is a cleavable disulfide ADC linker precursor facilitating thiol-reactive conjugation. Widely applied in antibody-drug conjugate chemistry for controlled payload release and linker stability.
Structure of 1807530-16-0
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
2-Hydroxyethyl disulfide mono-tosylate is a chemical reagent with a variety of specialized applications in the biosciences. Here are some key applications of 2-Hydroxyethyl disulfide mono-tosylate:
Protein Engineering: In the field of protein engineering, 2-Hydroxyethyl disulfide mono-tosylate is used to introduce disulfide bonds into proteins, stabilizing their structure. This can enhance the proteins' thermal and proteolytic stability, making them more suitable for industrial or therapeutic applications. Researchers utilize this reagent to improve protein folding and stability, which is critical for creating effective biopharmaceuticals.
Chemical Synthesis: 2-Hydroxyethyl disulfide mono-tosylate is employed in organic synthesis as an intermediate in the preparation of more complex molecules. Its tosylate group makes it a useful leaving group, facilitating various substitution reactions. Chemists often use it in the synthesis of sulfur-containing compounds, which are prevalent in many pharmaceuticals and fine chemicals.
Redox Biology Studies: This reagent is valuable in studying redox biology, particularly in the formation and breaking of disulfide bonds within biochemical systems. By introducing 2-Hydroxyethyl disulfide mono-tosylate, scientists can probe the dynamics of redox reactions and oxidative stress in cells. This helps in understanding the role of disulfide bonds in protein function and signaling pathways.
Drug Development: In drug development, 2-Hydroxyethyl disulfide mono-tosylate may be utilized to create prodrugs or modify drug molecules to enhance their bioavailability and stability. By attaching this moiety, researchers can influence the pharmacokinetic properties of therapeutic agents. This strategy is particularly useful in designing drugs with improved efficacy and reduced side effects.
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.